Justerede OR for myopati med sidste statin (med eller uden gemfibrozil) sammenlignet med ikke- samtidig cerivastatin var ikke væsentlige.
Adjusted Odds Ratios for myopathy with the last statin (with or without gemfibrozil) compared to non-concurrent cerivastatin were not significant.